CBA Pharma Vision Statement

CBA Pharma's vision is to provide hope and opportunity for a normal life span with an improved quality of life to people with life threatening disease.

The unifying principle of "Many Minds, One Heart"™ is the core of the philosophical foundation of CBA Pharma. It best reflects the pioneering research and product development successes achieved over the past decade leading to the creation of this company. It signifies the focused intent of many individuals (employees, shareholders, consultants, clinical investigators, etc.) toward a common vision.

"Many Minds, One Heart"™

Our unifying principle means that we, as a company, collaborate the intelligence and creativity of the minds in our entire organization and our many alliances toward the single heartfelt intent of helping others to heal their disease.

Hope For Cancer Patients
A promising compound, CBT-1™, that reduces drug resistance to chemotherapy has entered Phase III Human Clinical Trials of the United States Food and Drug Administration. The Phase III Clinical Trials are for Non-Small Cell Lung Cancer patients.